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BackgroundandObjectives.ThehumanleukocyteantigenHLA-B27isaclass1antigenofthemajorhistocompatibilitycomplexand
is strongly associated with ankylosing spondylitis (AS). The purpose of the present study is to investigate the distribution of HLA-
B27inpatients withASofdiﬀerent ethnicgroups in Qatar. DesignandSetting.Studydesignwascross-sectionalandthesettingwas
rheumatology clinics of Hamad General Hospital in Qatar where most of ankylosing spondylitis patients are followed up. Patients
and Methods. Patients with diagnosis of AS who met the New York modiﬁed criteria for AS were tested for HLA-B27. 119 patients
were tested for HLA-B27: 66 Arabs, 52 Asians (Indians, Pakistanis, Bengalis, and Iranians), and one Western (Irish). Results.O f
all the individuals, 82 were positive (69%) for HLA-B27. Among the Arabs, 49/66 were positive (74%). Among the Asians, 32/52
were positive (61%). Furthermore, Qatari patients (10 males and one female) 9 were positive (82%), 14/19 Jordanians/Palestinians
were positive, and 9/10 (90%) Egyptians were positive. Among the Asians, 19/26 Indians were positive (73%), which was similar
to the Arabs. Conclusion. HLA-B27 in our small group of Arabs is present in 74%. Comparison with other data will be presented
in detail.
1.Introduction
The human leukocyte antigen (HLA-B27) is a class I antigen
of the major histocompatibility complex, and it is strongly
associated with ankylosing spondylitis and other related
spondyloarthropathies (SpAs). It is present in only 8% of the
general population worldwide [1]. In the Middle East, lower
ﬁgures were reported from Arab countries, that is, United
Arab Emirates (UAE) 0.5%, Saudi Arabia 2.6%, Kuwait 4%,
Iraq 2.1%, Lebanon 1.4%, Tunisia 3.2%, and Syria 1.4% [2–
8]. On the other hand, a remarkably higher percentage was
found in Yemeni population (17%) [9].
InASpatients,HLA-B27ispresentin80–95%worldwide
[1]. The prevalence of HLA-B27 among AS patients in the
Arab world is generally lower than the worldwide ﬁgure,
ranging from 56 to 84%: 84% in Iraq, 56% in UAE, 67% in
Saudi Arabia, 58.6% in Egypt, 60% in Syria, and 73.4% in
Iran [5, 9–12].
The prevalence of HLA-B27 among healthy persons and
patients with AS in Qatar is unknown.
In this study we tested 119 of AS patients followed in
rheumatology outpatient clinics of Hamad General Hospital
in Qatar for the status of HLA-B27. This is the ﬁrst study in
Qatar to assess the prevalence of HLA-B27 among patients
with AS who are residents of Qatar (locals and expatriates).
2. Patients andMethods
One hundred nineteen patients with diagnosis of AS who
met the 1984 New York modiﬁed criteria for AS were tested
for HLA-B27. There were 66 Arabs (55.5%), 52 Asians
(43.7%), and one Western. Among the Arabs, 11 were
Qataris (9.2%) (10 males and 1 female), 19 were Jordanians/
Palestinians (15.9%), 10 were Egyptians (8.4%), and 26 were
of other Arab nationalities. Among the Asians, 26 were
Indians (21.8%) and 26 were of other Asian nationalities for
example, Pakistanis, Bengalis, and Iranians.
Qatar is an Arab country, in the Middle East, occupying
the small Qatar Peninsula on the northeasterly coast of
the much larger Arabian Peninsula. The total Population2 International Journal of Rheumatology
Table 1: HLA-B27 distribution among patients with AS in Qatar.
Nationality Number +ve HLA-B27
Qataris 11 09 (82%)
Jordanians/Palestinians 19 14 (72%)
Egyptians 10 09 (90%)
Iraqis 05 04 (80%)
Omanis 04 03 (75%)
Sudanese 04 03 (75%)
Syrians 04 02 (50%)
Lebanese 04 02 (50%)
Yemenis 03 02 (66%)
Algerians 02 01 (50%)
Indians 26 19 (73%)
Pakistanis 12 07 (58%)
Bengalis 08 03 (37.5%)
Iranians 06 03 (50%)
Irish 01 01 (100%)
of Qatar is 1,670,389 individuals, 1,270,968 males and
399,421 females [13]. Expatriates form the majority of Qatar
residents, nearly 3/4th of the population.
3. Results
Of all the individuals (119), 82 were HLA-B27 positive
(69%). Among the Arabs, 49/66 were positive (74%) and
among the Asians 32/52 were positive (61%). Positive HLA-




This study was conducted to assess the prevalence of HLA-
B27 among patients with AS living in Qatar. The overall
percentage was 69% and a higher prevalence was found
among locals (82%). This prevalence in Qataris is close to
the prevalence in the West and to the prevalence reported in
Jordan of 75 and 81% and in Iraq of 84% [5, 14, 15].
Data from other Arabian Gulf countries shows that the
prevalence of HLA-B27 is lower. In UAE, Al Attia found
the percentage to be 56% among Arabs although none of
them were locals and the study sample was rather small (28
pts.) [9]. It is worth mentioning that the percentage of HLA-
B27 among Emirian Arabs is extremely low (0.5%) [2]. In
Saudi Arabia, HLA-B27 was checked in 12/15 Arabs, locals
comprised 6/15, and the percentage was only 67% [10]. In
Kuwait, the percentage was higher (77.8%), but Kuwaitis
were only 9 out of 58 [16]. In our study the percentage in 19
Jordanian patients was 72%, this was slightly lower than the
ﬁndings in 2 Jordanian papers, 75% in the ﬁrst paper with
total of 20 patients tested and 81% in the second paper with
totalof52patientstested[14,15].TenEgyptianpatientswere
tested in our study and the result was positive in 9 of them
(90%), which is still within the worldwide ﬁgure but much
higher than the data from Egypt (58.6%) [11]. Our study
included the Asian population also, and, among 26 Indians,
73% were HLA-B27 positive, this is close to the frequency
reported among Indians in studies done in the Middle East
and India [9, 17].
5. Conclusion
This is the ﬁrst study to evaluate the prevalence of HLA-
B27 among AS patients living in Qatar. The population
studied includes locals, other Arabs, and Asians. The results
suggest that prevalence of HLA-B27 among Qatari patients
is similar to the prevalence seen in the West. There is a lack
of knowledge about the percentage of HLA-B27 in healthy
Qataris.
Further studies with larger number of patients and
studies that look at the prevalence of AS in Qatar and at the
prevalence of HLA-B27 in healthy Qataris are needed.
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